Literature DB >> 16105764

A novel chromosomal abnormality, t(6;10)(q27;q22), found in a polycythemic potential donor for allogeneic hematopoietic stem cell transplantation.

Hideki Mitsui1, Norimitsu Saito, Atsushi Satake, Tsuyoshi Nakazawa, Takahiro Karasuno, Akira Hiraoka.   

Abstract

A 59-year-old man was a potential donor for allogeneic hematopoietic stem cell transplantation and was found to be healthy but slightly polycythemic. The bone marrow was morphologically normal, but karyotyping of bone marrow cells showed t(6;10)(q27;q22) in 7 of 20 metaphases analyzed by G-banding and only the t(6;10) abnormality in 3 of 5 metaphases analyzed by the spectral karyotyping method. G-banding analysis of peripheral blood mononuclear cells cultured with phytohemagglutinin for 72 hours showed a normal karyotype in all 20 metaphases analyzed.These findings suggest clonal expansion with t(6;10)(q27;q22) in the bone marrow of this individual. He was determined to be ineligible for donation. A coordinated nationwide work-up for older donors is necessary to ensure high-quality standards.

Entities:  

Mesh:

Year:  2005        PMID: 16105764     DOI: 10.1532/IJH97.05027

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation.

Authors:  K D Berg; N K Brinster; K M Huhn; M G Goggins; R J Jones; A Makary; K M Murphy; C A Griffin; L S Rosenblum-Vos; M J Borowitz; H C Nousari; J R Eshleman
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

Review 2.  Transmission of donor illness by stem cell transplantation: should screening be different in older donors?

Authors:  D Niederwieser; C Gentilini; U Hegenbart; T Lange; P Moosmann; W Pönisch; H Al-Ali; M Raida; P Ljungman; A Tyndall; A Urbano-Ispizua; H M Lazarus; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

3.  Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.

Authors:  Frederic Baron; Marie-Françoise Dresse; Yves Beguin
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

4.  A chromosomal profile of polycythemia vera.

Authors:  G Rege-Cambrin; C Mecucci; G Tricot; J L Michaux; A Louwagie; W Van Hove; H Francart; H Van den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1987-04

5.  Chromosome studies in polycythemia vera patients.

Authors:  R Berger; A Bernheim; M Le Coniat; D Vecchione; G Flandrin; C Dresch; Y Najean
Journal:  Cancer Genet Cytogenet       Date:  1984-07

6.  Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.

Authors:  José L Vizmanos; Roberto Hernández; María J Vidal; María J Larráyoz; María D Odero; Julián Marín; María T Ardanaz; María J Calasanz; Nicholas C P Cross
Journal:  Hematol J       Date:  2004

7.  LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).

Authors:  Ryoichi Ono; Tomohiko Taki; Takeshi Taketani; Masafumi Taniwaki; Hajime Kobayashi; Yasuhide Hayashi
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

8.  FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.

Authors:  Geraldine Guasch; Bénédicte Delaval; Christine Arnoulet; Min-Jue Xie; Luc Xerri; Danielle Sainty; Daniel Birnbaum; Marie-Joséphe Pébusque
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

9.  Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.

Authors:  T L Kiss; H Chang; A Daly; H A Messner; N Jamal; D Spaner; S Rubin; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2004-04       Impact factor: 5.483

10.  A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course.

Authors:  B Swolin; A Weinfeld; J Westin
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.